{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:07:58Z","timestamp":1772028478537,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11030-020-10169-0","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T02:03:13Z","timestamp":1609639393000},"page":"1839-1854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["RETRACTED ARTICLE: CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3681-114X","authenticated-orcid":false,"given":"Amgad M.","family":"Rabie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"10169_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","volume":"91","author":"DS Hui","year":"2020","unstructured":"Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E (2020) The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health\u2014the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 91:264\u2013266. https:\/\/doi.org\/10.1016\/j.ijid.2020.01.009","journal-title":"Int J Infect Dis"},{"key":"10169_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.micinf.2020.02.002","volume":"22","author":"JY Li","year":"2020","unstructured":"Li JY, You Z, Wang Q, Zhou ZJ, Qiu Y, Luo R, Ge XY (2020) The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes Infect 22:80\u201385. https:\/\/doi.org\/10.1016\/j.micinf.2020.02.002","journal-title":"Microbes Infect"},{"key":"10169_CR3","doi-asserted-by":"publisher","unstructured":"Jiang S, Du L, Shi Z (2020) An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg Microbes Infect 9:275\u2013277. https:\/\/doi.org\/10.1080\/22221751.2020.1723441. Erratum: Jiang S (2020) Correction. Emerg Microbes Infect 9:539. https:\/\/doi.org\/10.1080\/22221751.2020.1737363","DOI":"10.1080\/22221751.2020.1723441"},{"key":"10169_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5582\/ddt.2020.01012","volume":"14","author":"L Dong","year":"2020","unstructured":"Dong L, Hu S, Gao J (2020) Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther 14:58\u201360. https:\/\/doi.org\/10.5582\/ddt.2020.01012","journal-title":"Drug Discov Ther"},{"key":"10169_CR5","doi-asserted-by":"publisher","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","volume":"178","author":"KT Choy","year":"2020","unstructured":"Choy KT, Wong AY, Kaewpreedee P, Sia SF, Chen D, Hui KPY, Chu DKW, Chan MCW, Cheung PP, Huang X, Peiris M, Yen HL (2020) Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res 178:104786. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104786","journal-title":"Antiviral Res"},{"key":"10169_CR6","doi-asserted-by":"publisher","first-page":"117477","DOI":"10.1016\/j.lfs.2020.117477","volume":"248","author":"AA Elfiky","year":"2020","unstructured":"Elfiky AA (2020) Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci 248:117477. https:\/\/doi.org\/10.1016\/j.lfs.2020.117477","journal-title":"Life Sci"},{"key":"10169_CR7","doi-asserted-by":"publisher","unstructured":"Elfiky AA (2020) Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study. Life Sci 253:117592. https:\/\/doi.org\/10.1016\/j.lfs.2020.117592. Erratum: Elfiky AA (2020) Corrigendum. Life Sci 258:118350. https:\/\/doi.org\/10.1016\/j.lfs.2020.118350","DOI":"10.1016\/j.lfs.2020.117592"},{"key":"10169_CR8","doi-asserted-by":"publisher","first-page":"104793","DOI":"10.1016\/j.antiviral.2020.104793","volume":"178","author":"A Shannon","year":"2020","unstructured":"Shannon A, Le NT, Selisko B, Eydoux C, Alvarez K, Guillemot JC, Decroly E, Peersen O, Ferron F, Canard B (2020) Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 exonuclease active-sites. Antiviral Res 178:104793. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104793","journal-title":"Antiviral Res"},{"key":"10169_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30:269\u2013271. https:\/\/doi.org\/10.1038\/s41422-020-0282-0","journal-title":"Cell Res"},{"key":"10169_CR10","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1126\/science.abc1560","volume":"368","author":"W Yin","year":"2020","unstructured":"Yin W, Mao C, Luan X, Shen DD, Shen Q, Su H, Wang X, Zhou F, Zhao W, Gao M, Chang S, Xie YC, Tian G, Jiang HW, Tao SC, Shen J, Jiang Y, Jiang H, Xu Y, Zhang S, Zhang Y, Xu HE (2020) Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science 368:1499\u20131504. https:\/\/doi.org\/10.1126\/science.abc1560","journal-title":"Science"},{"key":"10169_CR11","doi-asserted-by":"publisher","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","volume":"178","author":"L Caly","year":"2020","unstructured":"Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM (2020) The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 178:104787. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104787","journal-title":"Antiviral Res"},{"key":"10169_CR12","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.eng.2020.03.007","volume":"6","author":"Q Cai","year":"2020","unstructured":"Cai Q, Yang M, Liu D, Chen J, Shu D, Xia J, Liao X, Gu Y, Cai Q, Yang Y, Shen C, Li X, Peng L, Huang D, Zhang J, Zhang S, Wang F, Liu J, Chen L, Chen S, Wang Z, Zhang Z, Cao R, Zhong W, Liu Y, Liu L (2020) Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering 6:1192\u20131198. https:\/\/doi.org\/10.1016\/j.eng.2020.03.007","journal-title":"Engineering"},{"key":"10169_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/cpt.1844","volume":"108","author":"YX Du","year":"2020","unstructured":"Du YX, Chen XP (2020) Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection. Clin Pharmacol Ther 108:242\u2013247. https:\/\/doi.org\/10.1002\/cpt.1844","journal-title":"Clin Pharmacol Ther"},{"key":"10169_CR14","doi-asserted-by":"publisher","first-page":"107512","DOI":"10.1016\/j.pharmthera.2020.107512","volume":"209","author":"K Shiraki","year":"2020","unstructured":"Shiraki K, Daikoku T (2020) Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacol Ther 209:107512. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107512","journal-title":"Pharmacol Ther"},{"key":"10169_CR15","doi-asserted-by":"publisher","first-page":"109815","DOI":"10.1016\/j.mehy.2020.109815","volume":"142","author":"R Derwand","year":"2020","unstructured":"Derwand R, Scholz M (2020) Does zinc supplementation enhance the clinical efficacy of chloroquine\/hydroxychloroquine to win today\u2019s battle against COVID-19? Med Hypotheses 142:109815. https:\/\/doi.org\/10.1016\/j.mehy.2020.109815","journal-title":"Med Hypotheses"},{"key":"10169_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","volume":"6","author":"J Liu","year":"2020","unstructured":"Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, Li Y, Hu Z, Zhong W, Wang M (2020) Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov 6:16. https:\/\/doi.org\/10.1038\/s41421-020-0156-0","journal-title":"Cell Discov"},{"key":"10169_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41421-020-0169-8","volume":"6","author":"X Wang","year":"2020","unstructured":"Wang X, Cao R, Zhang H, Liu J, Xu M, Hu H, Li Y, Zhao L, Li W, Sun X, Yang X, Shi Z, Deng F, Hu Z, Zhong W, Wang M (2020) The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro. Cell Discov 6:28. https:\/\/doi.org\/10.1038\/s41421-020-0169-8","journal-title":"Cell Discov"},{"key":"10169_CR18","doi-asserted-by":"publisher","first-page":"112559","DOI":"10.1016\/j.ejmech.2020.112559","volume":"201","author":"S Abdul Amin","year":"2020","unstructured":"Abdul Amin S, Jha T (2020) Fight against novel coronavirus: a perspective of medicinal chemists. Eur J Med Chem 201:112559. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112559","journal-title":"Eur J Med Chem"},{"key":"10169_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1021\/acscombsci.0c00058","volume":"22","author":"B Goyal","year":"2020","unstructured":"Goyal B, Goyal D (2020) Targeting the dimerization of the main protease of coronaviruses: a potential broad-spectrum therapeutic strategy. ACS Comb Sci 22:297\u2013305. https:\/\/doi.org\/10.1021\/acscombsci.0c00058","journal-title":"ACS Comb Sci"},{"key":"10169_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5923\/j.ajoc.20160602.02","volume":"6","author":"AM Rabie","year":"2016","unstructured":"Rabie AM, Tantawy AS, Badr SMI (2016) Design, synthesis, and biological evaluation of novel 5-substituted-2-(3,4,5-trihydroxyphenyl)-1,3,4-oxadiazoles as potent antioxidants. Am J Org Chem 6:54\u201380. https:\/\/doi.org\/10.5923\/j.ajoc.20160602.02","journal-title":"Am J Org Chem"},{"key":"10169_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.34297\/AJBSR.2019.02.000566","volume":"2","author":"T Ishida","year":"2019","unstructured":"Ishida T (2019) Review on the role of Zn2+ ions in viral pathogenesis and the effect of Zn2+ ions for host cell-virus growth inhibition. Am J Biomed Sci Res 2:28\u201337. https:\/\/doi.org\/10.34297\/AJBSR.2019.02.000566","journal-title":"Am J Biomed Sci Res"},{"key":"10169_CR22","doi-asserted-by":"publisher","first-page":"e1001176","DOI":"10.1371\/journal.ppat.1001176","volume":"6","author":"AJ te Velthuis","year":"2010","unstructured":"te Velthuis AJ, van den Worm SH, Sims AC, Baric RS, Snijder EJ, van Hemert MJ (2010) Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog 6:e1001176. https:\/\/doi.org\/10.1371\/journal.ppat.1001176","journal-title":"PLoS Pathog"},{"key":"10169_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"key":"10169_CR24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"C Wu","year":"2020","unstructured":"Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M, Chen L, Li H (2020) Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B 10:766\u2013788. https:\/\/doi.org\/10.1016\/j.apsb.2020.02.008","journal-title":"Acta Pharm Sin B"},{"key":"10169_CR25","unstructured":"COVID-19 Docking Server Web-based Software, COVID-19 Docking Server (Homepage on the Internet), Shan Change Lab., Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001, China, 2020; Available from COVID-19 Docking Server on the Web (homepage: http:\/\/ncov.schanglab.org.cn); Results obtained through using interactive docking tool in COVID-19 Docking Server (Copyright\u00a9 2018\u20132023, Shan Chang; Version 2020) on this website (accessed and cited in 2020, 11\u201322 June), and references cited therein."},{"key":"10169_CR26","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gkv315","volume":"43","author":"S Salentin","year":"2015","unstructured":"Salentin S, Schreiber S, Haupt VJ, Adasme MF, Schroeder M (2015) PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Res 43:W443\u2013W447. https:\/\/doi.org\/10.1093\/nar\/gkv315","journal-title":"Nucleic Acids Res"},{"key":"10169_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/clinchem\/hvaa029","volume":"66","author":"DKW Chu","year":"2020","unstructured":"Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, Peiris M, Poon LLM (2020) Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem 66:549\u2013555. https:\/\/doi.org\/10.1093\/clinchem\/hvaa029","journal-title":"Clin Chem"},{"key":"10169_CR28","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","volume":"63","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R (2020) \u03b1-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment. J Med Chem 63:4562\u20134578. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01828","journal-title":"J Med Chem"}],"updated-by":[{"DOI":"10.1007\/s11030-022-10521-6","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"record-id":"38854"},{"DOI":"10.1007\/s11030-020-10169-0","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000}},{"DOI":"10.1007\/s11030-022-10521-6","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000}}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-020-10169-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-020-10169-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-020-10169-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:06:08Z","timestamp":1772024768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-020-10169-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10169"],"URL":"https:\/\/doi.org\/10.1007\/s11030-020-10169-0","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"7 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11030-022-10521-6","URL":"https:\/\/doi.org\/10.1007\/s11030-022-10521-6","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"I hereby declare that I totally have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this new research paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}